Pierre Youinou: When intuition and determination meet autoimmunity

Journal of Autoimmunity

Volumn 39, Issue 3, 2012, Pages 117-120

  Jamin, Christophe ^a,b   Renaudineau, Yves ^a,b   Pers, Jacques Olivier ^a,b  

^a UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^b CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CD5 ANTIGEN; ENDOTHELIAL CELL ANTIBODY;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL RESEARCH; EDITORIAL; HUMAN; MEDICAL PRACTICE; PRIORITY JOURNAL;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; FRANCE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 84865366747     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.05.004     Document Type: Editorial

References (118)

1. Youinou P.Y., Irving W.L., Shipley M., Hayes J., Lydyard P.M. Evidence for B cell activation in patients with active rheumatoid arthritis. Clin Exp Immunol 1984, 55:91-98.
2. Youinou P., Mackenzie L., Broker B.M., Isenberg D.I., Drogou-Lelong A., Gentric A., et al. The importance of CD5-positive B cells in nonorgan-specific autoimmune diseases. Scand J Rheumatol Suppl 1988, 76:243-249.
3. Youinou P., Mackenzie L.E., Lamour A., Mageed R.A., Lydyard P.M. Human CD5-positive B cells in lymphoid malignancy and connective tissue diseases. Eur J Clin Invest 1993, 23:139-150.
4. Youinou P., Jamin C., Lydyard P.M. CD5 expression in human B-cell populations. Immunol Today 1999, 20:312-316.
5. Renaudineau Y., Pers J.O., Bendaoud B., Jamin C., Youinou P. Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev 2004, 3:516-523.
6. Youinou P., Hillion S., Jamin C., Pers J.O., Saraux A., Renaudineau Y. B lymphocytes on the front line of autoimmunity. Autoimmun Rev 2006, 5:215-221.
7. Youinou P. B cell conducts the lymphocyte orchestra. J Autoimmun 2007, 28:143-151.
8. Binard A., Le Pottier L., Saraux A., Devauchelle-Pensec V., Pers J.O., Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?. J Autoimmun 2008, 30:63-67.
9. Youinou P., Taher T.E., Pers J.O., Mageed R.A., Renaudineau Y. B lymphocyte cytokines and rheumatic autoimmune disease. Arthritis Rheum 2009, 60:1873-1880.
10. Youinou P., Pers J.O., Gershwin M.E., Shoenfeld Y. Geo-epidemiology and autoimmunity. J Autoimmun 2010, 34:J163-J167.
11. Segalen I., Fali T., Pers J.O., Le Meur Y., Youinou P., Loisel S. A case for the graft-versus-host disease as a model for B cell-mediated autoimmunity. Autoimmun Rev 2011, 10:218-221.
12. Tobon G.J., Pers J.O., Canas C.A., Rojas-Villarraga A., Youinou P., Anaya J.M. Are autoimmune diseases predictable?. Autoimmun Rev 2012, 11:259-266.
13. Youinou P., Le Goff P., Blain F., Le Menn G. Association of systemic scleroderma, hepatopathy and Gougerot-Sjogren syndrome. 2 cases: coincidence of pathogenic relationship?. Nouv Presse Med 1976, 5:1983-1985.
14. Youinou P., Le Goff P., Miossec P., L'Hostis D. Rheumatoid arthritis with IgE type rheumatoid factors. Rev Rhum Mal Osteoartic 1982, 49:453-456.
15. Youinou P., Dorval J.C., Cledes J., Leroy J.P., Miossec P., Masse R. A study of familial lupus erythematosus-like disease and hereditary angio-oedema treated with danazol. Br J Dermatol 1983, 108:717-722.
16. Youinou P., Mackenzie L., Jouquan J., Le Goff P., Lydyard P.M. CD5 positive B cells in patients with rheumatoid arthritis: phorbol ester mediated enhancement of detection. Ann Rheum Dis 1987, 46:17-22.
17. Youinou P., Mackenzie L., Katsikis P., Merdrignac G., Isenberg D.A., Tuaillon N., et al. The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. Arthritis Rheum 1990, 33:339-348.
18. Youinou P., Mackenzie L., le Masson G., Papadopoulos N.M., Jouquan J., Pennec Y.L., et al. CD5-expressing B lymphocytes in the blood and salivary glands of patients with primary Sjogren's syndrome. J Autoimmun 1988, 1:185-194.
19. Garaud S., Morva A., Lemoine S., Hillion S., Bordron A., Pers J.O., et al. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation. J Immunol 2011, 186:4835-4844.
20. Jamin C., Le Corre R., Lydyard P.M., Youinou P. Anti-CD5 extends the proliferative response of human CD5+ B cells activated with anti-IgM and interleukin-2. Eur J Immunol 1996, 26:57-62.
21. Pers J.O., Jamin C., Le Corre R., Lydyard P.M., Youinou P. Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis. Eur J Immunol 1998, 28:4170-4176.
22. Renaudineau Y., Nedellec S., Berthou C., Lydyard P.M., Youinou P., Pers J.O. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells. Leukemia 2005, 19:223-229.
23. Renaudineau Y., Hillion S., Saraux A., Mageed R.A., Youinou P. An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes. Blood 2005, 106:2781-2789.
24. Renaudineau Y., Vallet S., Le Dantec C., Hillion S., Saraux A., Youinou P. Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes. Genes Immun 2005, 6:663-671.
25. Garaud S., Le Dantec C., Berthou C., Lydyard P.M., Youinou P., Renaudineau Y. Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes. J Immunol 2008, 181:2010-2018.
26. Brooks W.H., Le Dantec C., Pers J.O., Youinou P., Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010, 34:J207-J219.
27. Lu Q., Renaudineau Y., Cha S., Ilei G., Brooks W.H., Selmi C., et al. Epigenetics in autoimmune disorders: highlights of the 10th Sjogren's syndrome symposium. Autoimmun Rev 2010, 9:627-630.
28. Youinou P., Pers J.O. The late news on baff in autoimmune diseases. Autoimmun Rev 2010, 9:804-806.
29. Pers J.O., Devauchelle V., Daridon C., Bendaoud B., Le Berre R., Bordron A., et al. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjogren's syndrome. Arthritis Rheum 2007, 56:1464-1477.
30. Daridon C., Devauchelle V., Hutin P., Le Berre R., Martins-Carvalho C., Bendaoud B., et al. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 2007, 56:1134-1144.
31. Pers J.O., Daridon C., Devauchelle V., Jousse S., Saraux A., Jamin C., et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 2005, 1050:34-39.
32. d'Arbonneau F., Pers J.O., Devauchelle V., Pennec Y., Saraux A., Youinou P. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjogren's syndrome. Arthritis Rheum 2006, 54:115-126.
33. Varin M.M., Le Pottier L., Youinou P., Saulep D., Mackay F., Pers J.O. B-cell tolerance breakdown in Sjogren's syndrome: focus on BAFF. Autoimmun Rev 2010, 9:604-608.
34. Le Pottier L., Bendaoud B., Renaudineau Y., Youinou P., Pers J.O., Daridon C. New ELISA for B cell-activating factor. Clin Chem 2009, 55:1843-1851.
35. Youinou P., Devauchelle-Pensec V., Pers J.O. Significance of B cells and B cell clonality in Sjogren's syndrome. Arthritis Rheum 2010, 62:2605-2610.
36. Varin M.M., Guerrier T., Devauchelle-Pensec V., Jamin C., Youinou P., Pers J.O. Sjogren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev 2012, 11:252-258.
37. Youinou P., Daridon C., Saraux A., Devauchelle V., Pers J.O. Is B-cell the conductor of the lymphocyte orchestra in the salivary glands of patients with primary Sjogren's syndrome. Clin Exp Rheumatol 2006, 24:491-492.
38. Binard A., Le Pottier L., Devauchelle-Pensec V., Saraux A., Youinou P., Pers J.O. Is the blood B-cell subset profile diagnostic for Sjogren syndrome?. Ann Rheum Dis 2009, 68:1447-1452.
39. Daridon C., Guerrier T., Devauchelle V., Saraux A., Pers J.O., Youinou P. Polarization of B effector cells in Sjogren's syndrome. Autoimmun Rev 2007, 6:427-431.
40. Le Pottier L., Devauchelle V., Fautrel A., Daridon C., Saraux A., Youinou P., et al. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009, 182:3540-3547.
41. Daridon C., Pers J.O., Devauchelle V., Martins-Carvalho C., Hutin P., Pennec Y.L., et al. Identification of transitional type II B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 2006, 54:2280-2288.
42. Guerrier T., Le Pottier L., Devauchelle V., Pers J.O., Jamin C., Youinou P. Role of toll-like receptors in primary Sjogren's syndrome with a special emphasis on B-cell maturation within exocrine tissues. J Autoimmun 2012, 39(1-2):69-76.
43. Le Pottier L., Devauchelle V., Pers J.O., Jamin C., Youinou P. The mosaic of B-cell subsets (with special emphasis on primary Sjogren's syndrome). Autoimmun Rev 2007, 6:149-154.
44. Tobon G.J., Pers J.O., Youinou P., Saraux A. B cell-targeted therapies in Sjogren's syndrome. Autoimmun Rev 2010, 9:224-228.
45. Devauchelle-Pensec V., Pennec Y., Morvan J., Pers J.O., Daridon C., Jousse-Joulin S., et al. Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum 2007, 57:310-317.
46. Youinou P., Le Dantec C., Bendaoud B., Renaudineau Y., Pers J.O., Jamin C. Endothelium, a target for immune-mediated assault in connective tissue disease. Autoimmun Rev 2006, 5:222-228.
47. Alard J.E., Dueymes M., Youinou P., Jamin C. Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases. Autoimmun Rev 2007, 6:438-443.
48. Tobon G.J., Alard J.E., Youinou P., Jamin C. Are autoantibodies triggering endothelial cell apoptosis really pathogenic?. Autoimmun Rev 2009, 8:605-610.
49. Bordron A., Revelen R., D'Arbonneau F., Dueymes M., Renaudineau Y., Jamin C., et al. Functional heterogeneity of anti-endothelial cell antibodies. Clin Exp Immunol 2001, 124:492-501.
50. Bordron A., Dueymes M., Levy Y., Jamin C., Ziporen L., Piette J.C., et al. Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum 1998, 41:1738-1747.
51. Bordron A., Dueymes M., Levy Y., Jamin C., Leroy J.P., Piette J.C., et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998, 101:2029-2035.
52. Alard J.E., Gaillard F., Daridon C., Shoenfeld Y., Jamin C., Youinou P. TLR2 is one of the endothelial receptors for beta 2-glycoprotein I. J Immunol 2010, 185:1550-1557.
53. Alard J.E., Dueymes M., Mageed R.A., Saraux A., Youinou P., Jamin C. Mitochondrial heat shock protein (HSP) 70 synergizes with HSP60 in transducing endothelial cell apoptosis induced by anti-HSP60 autoantibody. FASEB J 2009, 23:2772-2779.
54. Alard J.E., Hillion S., Guillevin L., Saraux A., Pers J.O., Youinou P., et al. Autoantibodies to endothelial cell surface ATP synthase, the endogenous receptor for hsp60, might play a pathogenic role in vasculatides. PLoS One 2011, 6:e14654.
55. Durand V., Pers J.O., Renaudineau Y., Saraux A., Youinou P., Jamin C. Differential effects of anti-Fc gamma RIIIb autoantibodies on polymorphonuclear neutrophil apoptosis and function. J Leukoc Biol 2001, 69:233-240.
56. Durand V., Renaudineau Y., Pers J.O., Youinou P., Jamin C. Cross-linking of human FcgammaRIIIb induces the production of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor by polymorphonuclear neutrophils. J Immunol 2001, 167:3996-4007.
57. Durand V., Pers J.O., Renaudineau Y., Youinou P., Jamin C. Soluble Fcgamma receptor IIIb alters the function of polymorphonuclear neutrophils but extends their survival. Eur J Immunol 2001, 31:1952-1961.
58. Youinou P., Durand V., Renaudineau Y., Pennec Y.L., Saraux A., Jamin C. Pathogenic effects of anti-Fc gamma receptor IIIb (CD16) on polymorphonuclear neutrophils in non-organ-specific autoimmune diseases. Autoimmun Rev 2002, 1:13-19.
59. Lemoine S., Morva A., Youinou P., Jamin C. Human T cells induce their own regulation through activation of B cells. J Autoimmun 2011, 36:228-238.
60. Morva A., Lemoine S., Achour A., Pers J.O., Youinou P., Jamin C. Maturation and function of human dendritic cells are regulated by B lymphocytes. Blood 2012, 119:106-114.
61. Jamin C., Morva A., Lemoine S., Daridon C., de Mendoza A.R., Youinou P. Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum 2008, 58:1900-1906.
62. Youinou P., Pers J.O. The international symposium on Sjogren's syndrome in Brest: the "top of the tops" at the "tip of the tips". Autoimmun Rev 2010, 9:589-590.
63. Arnson Y., Shoenfeld Y., Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010, 34:J258-J265.
64. Biggioggero M., Meroni P.L. The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 2010, 9:A299-A304.
65. Bizzaro N., Tozzoli R., Shoenfeld Y. Are we at a stage to predict autoimmune rheumatic diseases?. Arthritis Rheum 2007, 56:1736-1744.
66. Borchers A.T., Naguwa S.M., Keen C.L., Gershwin M.E. The implications of autoimmunity and pregnancy. J Autoimmun 2010, 34:J287-J299.
67. Borchers A.T., Naguwa S.M., Shoenfeld Y., Gershwin M.E. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010, 9:A277-A287.
68. Mackay I.R. Travels and travails of autoimmunity: a historical journey from discovery to rediscovery. Autoimmun Rev 2010, 9:A251-A258.
69. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjogren's syndrome. Autoimmun Rev 2010, 9:A305-A310.
70. Borchers A.T., Uibo R., Gershwin M.E. The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010, 9:A355-A365.
71. Chandran V., Raychaudhuri S.P. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010, 34:J314-J321.
72. Chang C. The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 2010, 34:J234-J246.
73. Chang C., Gershwin M.E. Drugs and autoimmunity-a contemporary review and mechanistic approach. J Autoimmun 2010, 34:J266-J275.
74. Chen M., Daha M.R., Kallenberg C.G. The complement system in systemic autoimmune disease. J Autoimmun 2010, 34:J276-J286.
75. Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev 2010, 9:A325-A329.
76. Gershwin M.E., Goetzl E.J., Steinberg A.D. Cyclophosphamide: use in practice. Ann Intern Med 1974, 80:531-540.
77. Chen M., Kallenberg C.G. The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 2010, 9:A293-A298.
78. Martin P.I., Malizia A.I., Rewald E. A propos time and autoimmunity. Clin Rev Allergy Immunol 2008, 34:380-384.
79. Maverakis E., Miyamura Y., Bowen M.P., Correa G., Ono Y., Goodarzi H. Light, including ultraviolet. J Autoimmun 2010, 34:J247-J257.
80. Deane S., Teuber S.S., Gershwin M.E. The geoepidemiology of immune thrombocytopenic purpura. Autoimmun Rev 2010, 9:A342-A349.
81. Hemminki K., Li X., Sundquist J., Sundquist K. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 2010, 34:J307-J313.
82. Berkun Y., Padeh S. Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 2010, 9:A319-A324.
83. Bhat A., Naguwa S., Cheema G., Gershwin M.E. The epidemiology of transverse myelitis. Autoimmun Rev 2010, 9:A395-A399.
84. Hershko A.Y., Naparstek Y. Autoimmunity in the era of genomics and proteomics. Autoimmun Rev 2006, 5:230-233.
85. Leung P.S., Shu S.A., Kenny T.P., Wu P.Y., Tao M.H. Development and validation of gene therapies in autoimmune diseases: epidemiology to animal models. Autoimmun Rev 2010, 9:A400-A405.
86. Lleo A., Invernizzi P., Gao B., Podda M., Gershwin M.E. Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun Rev 2010, 2010(9):A259-A266.
87. Hoffmann M.H., Trembleau S., Muller S., Steiner G. Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun 2010, 34:J178-J206.
88. Segelmark M., Hellmark T. Autoimmune kidney diseases. Autoimmun Rev 2010, 9:A366-A371.
89. Selmi C. The worldwide gradient of autoimmune conditions. Autoimmun Rev 2010, 9:A247-A250.
90. Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun 2010, 34:J300-J306.
91. Lambert J.F., Nydegger U.E. Geoepidemiology of autoimmune hemolytic anemia. Autoimmun Rev 2010, 9:A350-A354.
92. Logan I., Bowlus C.L. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010, 9:A372-A378.
93. Mackay I.R. The etiopathogenesis of autoimmunity. Semin Liver Dis 2005, 25:239-250.
94. Meyer A., Levy Y. Chapter 33: geoepidemiology of myasthenia gravis. Autoimmun Rev 2010, 9:A383-A386.
95. Powell J.J., Faria N., Thomas-McKay E., Pele L.C. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 2010, 34:J226-J233.
96. Selmi C., Tsuneyama K. Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 2010, 9:A267-A270.
97. Tobon G.J., Youinou P., Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 2010, 9:A288-A292.
98. Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun 2010, 34:J322-J326.
99. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010, 34:J168-J177.
100. Prieto S., Grau J.M. The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 2010, 9:A330-A334.
101. Ranque B., Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmun Rev 2010, 9:A311-A318.
102. Meyer N., Misery L. Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev 2010, 9:A379-A382.
103. Milo R., Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010, 9:A387-A394.
104. Round J.L., O'Connell R.M., Mazmanian S.K. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 2010, 34:J220-J225.
105. Sands J., Tuscano J.M. Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders. Autoimmun Rev 2010, 9:A335-A341.
106. Shoenfeld Y., Selmi C., Zimlichman E., Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 2008, 31:325-330.
107. Stojanovich L. Stress and autoimmunity. Autoimmun Rev 2010, 9:A271-A276.
108. Tonutti E., Visentini D., Bizzaro N. Interpretative comments on autoantibody tests. Autoimmun Rev 2007, 6:341-346.
109. Zeki A.A., Schivo M., Chan A.L., Hardin K.A., Kenyon N.J., Albertson T.E., et al. Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 2010, 34:J327-J338.
110. Youinou P., Haralampos M. Moutsopoulos: a lifetime in autoimmunity. J Autoimmun 2010, 35:171-175.
111. Miyagawa F., Gutermuth J., Zhang H., Katz S.I. The use of mouse models to better understand mechanisms of autoimmunity and tolerance. J Autoimmun 2010, 35:192-198.
112. Gershwin M.E., Shoenfeld Y. Chella David: a lifetime contribution in translational immunology. J Autoimmun 2011, 37:59-62.
113. Rose N.R. The genetics of autoimmune thyroiditis: the first decade. J Autoimmun 2011, 37:88-94.
114. Mackay I.R., Leskovsek N.V., Rose N.R. The odd couple A fresh look at autoimmunity and immunodeficiency. J Autoimmun 2010, 35:199-205.
115. Vlachoyiannopoulos P.G., Routsias J.G. A novel mechanism of thrombosis in antiphospholipid antibody syndrome. J Autoimmun 2010, 35:248-255.
116. Tsuda M., Torgerson T.R., Selmi C., Gambineri E., Careiro-Sampaio M., Manrurita S.C., et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun 2010, 35:265-268.
117. Fu S.M., Deshmukh U.S., Gaskin F. Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J Autoimmun 2011, 37:104-112.
118. Kapsogeorgou E.K., Gourzi V.C., Manoussakis M.N., Moutsopoulos H., Tzioufas A.G. Cellular microRNAs (miRNAs) and Sjogren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun 2011, 37:129-135.